» Articles » PMID: 9731568

A New Prognostic System for Hepatocellular Carcinoma: a Retrospective Study of 435 Patients: the Cancer of the Liver Italian Program (CLIP) Investigators

Overview
Journal Hepatology
Specialty Gastroenterology
Date 1998 Sep 10
PMID 9731568
Citations 488
Affiliations
Soon will be listed here.
Abstract

The clinical outcome of cirrhotic patients with hepatocellular carcinoma (HCC) depends both on the residual liver function and tumor characteristics. However, the relative prognostic weight of these variables is not well defined. The aims of this study were to verify the value of known prognostic factors and to devise a prognostic index more sensitive than the commonly used Okuda stage. A retrospective analysis of the cases of HCC diagnosed at 16 Italian institutions from 1990 to 1992 was performed. Overall survival was the only end point used in the analysis. The Cox model, stratified by locoregional treatment, was used for multivariate analyses. The final model was derived from 10 randomly chosen training samples, and the prognostic validity of the Cancer of the Liver Italian Program (CLIP) score was assessed on the corresponding testing samples. Four hundred thirty-five cases of HCC were collected. As of January 1997, 313 patients (72%) were deceased. Overall median survival was 20 months. At multivariate analysis, independent predictive factors of survival were Child-Pugh stage, tumor morphology, alpha-fetoprotein (AFP), and portal vein thrombosis. A simple scoring system (CLIP score) was thus produced, assigning linear scores (0/1/2) to the covariates. Compared with Okuda stage, the CLIP score, structured as a six-category tool, has a greater discriminant ability, revealing a class of patients with an impressively more favorable prognosis and another class with a relatively shorter life expectancy. The CLIP score is a new prognostic system that accounts for both liver function and tumor characteristics. It is easy to calculate and appears to give more precise information than the Okuda stage.

Citing Articles

Mixture of Expert-Based SoftMax-Weighted Box Fusion for Robust Lesion Detection in Ultrasound Imaging.

Rhyou S, Yu M, Yoo J Diagnostics (Basel). 2025; 15(5).

PMID: 40075835 PMC: 11899514. DOI: 10.3390/diagnostics15050588.


Psoas Muscle Index as an Independent Predictor of Survival in Patients with Hepatocellular Carcinoma Receiving Systemic Targeted Therapy.

Imai K, Takai K, Aiba M, Unome S, Miwa T, Hanai T Cancers (Basel). 2025; 17(2.

PMID: 39857991 PMC: 11763421. DOI: 10.3390/cancers17020209.


Nanomedicine Strategies Utilizing Lipid-Based Nanoparticles for Liver Cancer Therapy: Exploring Signaling Pathways and Therapeutic Modalities.

Asgharzadeh F, Moradi Binabaj M, Fanoudi S, Cho W, Yang Y, Azarian M Adv Pharm Bull. 2024; 14(3):513-523.

PMID: 39494254 PMC: 11530870. DOI: 10.34172/apb.2024.061.


Construction and validation of a preoperative prognostic model integrating the novel aspartate aminotransferase-albumin score for hepatocellular carcinoma patients undergoing liver resection.

Ikuta S, Aihara T, Kasai M, Nakajima T, Yamanaka N Ann Hepatobiliary Pancreat Surg. 2024; 28(4):440-450.

PMID: 39129152 PMC: 11599819. DOI: 10.14701/ahbps.24-110.


Decoding the Prognostic Significance and Therapeutic Implications of Inflammation-Based Scores in Hepatocellular Carcinoma: A Comprehensive Review.

Kotsifa E, Machairas N, Angelis A, Nikiteas N, Dimitroulis D, Sotiropoulos G Cancers (Basel). 2024; 16(14).

PMID: 39061188 PMC: 11274930. DOI: 10.3390/cancers16142549.